Mediclinic International PLC (LON:MDC) had its target price lowered by Jefferies Group from GBX 920 ($12.01) to GBX 833 ($10.87) in a research report sent to investors on Thursday morning. Jefferies Group currently has a hold rating on the stock.
Several other equities research analysts have also weighed in on the company. Citigroup Inc. lowered Mediclinic International PLC to a neutral rating and set a GBX 1,090 ($14.23) target price on the stock. in a research report on Monday, September 12th. JPMorgan Chase & Co. reaffirmed a neutral rating and set a GBX 1,160 ($15.14) price target on shares of Mediclinic International PLC in a research report on Tuesday, August 23rd. Finally, Macquarie reaffirmed a neutral rating and set a GBX 900 ($11.75) price target on shares of Mediclinic International PLC in a research report on Friday, May 27th. Seven research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and an average price target of GBX 967.43 ($12.63).
Mediclinic International PLC (LON:MDC) opened at 936.00 on Thursday. Mediclinic International PLC has a 12 month low of GBX 794.50 and a 12 month high of GBX 1,219.00. The stock’s 50 day moving average price is GBX 1,014.93 and its 200-day moving average price is GBX 961.47. The stock’s market cap is GBX 6.90 billion.
About Mediclinic International PLC
Mediclinic International plc, formerly Al Noor Hospitals Group plc, is a holding company. The Company operates as an international private healthcare provider. Its segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services.
Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with MarketBeat.com's FREE daily email newsletter.